Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines. More info »
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.
Tanzanian drugmaker to start producing ARVs in August - The Pharma Letter
Tanzanian drugmaker to start producing ARVs in AugustThe Pharma LetterThe company will produce the triple combination ingredients of ARV which includes stavudine, nevirapine and lamivudine.
LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
Patent expires of landmark HIV drug Combivir - U-T San Diego
Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.